(ii) Pertussis toxin blocks the growth inhibitory effects of SS-14, suggesting that inhibitory G proteins are involved in the mechanism of SS-14 action. Somatostatin may be useful in studying the role of second messengers in cell growth.
INTRODUCTION
Most of our knowledge about growth control in hepatocyte cell culture has been derived from observing the action of growth stimulants such as insulin, epidermal growth factor, and glucagon [ 11. The proliferative state is affected by the complex interactions of growth factors, ion flux, nutrient state, and growth inhibitors. In the case of hepatocytes, the inability to identify inhibitors and difficulties in distinguishing growth inhibition from cytotoxicity in cell culture have hampered the study of inhibitory growth regulation. Despite these difficulties, several compounds have been shown to inhibit hepatocyte growth, including transforming growth factor p (TGFP), arginase, and adrenal steroids [2]. Somatostatin (SS-14) has been shown to inhibitproliferation of a number of normal and neoplastic cell types in culture. Somatostatin has been shown to inhibit growth of pancreatic acinar cells, rat thyroid follicular cells, and lymphocytes [3-51. Somatostatin-14 and several analogs have also been shown to inhibit growth of cultured pancreatic tumor cells and can also inhibit proliferation of several breast cancer cell lines [6, 71. Although no work has been published looking at the effect of SS-14 on hepatocyte growth, it has been reported to inhibit rat liver regeneration in uiuo [8] . Recently, SS-14 has been shown to inhibit insulin-stimulated but not triiodothyronine-stimulated growth of the well-differentiated human hepatoma (Hep3B) cell line [9] .
Although no direct effects of SS-14 on hepatocyte growth have been previously reported, SS-14 appears to influence a number of hepatic functions. Several authors have documented a reduction in bile acid-independent canalicular bile flow in response to SS-14 in the intact rat as well as in an isolated, perfused rat liver [lo] . In humans, continuous intravenous infusion of SS-14 decreases output of bile, bile acid, cholesterol, andphospholipid [ll] . Evidence from several laboratories has recently shown that SS-14 may regulate liver function by blocking the effects of the intracellular second messenger, cyclic AMP [12, 131.
Based on evidence that somatostatin inhibits insulinstimulated Hep3B growth in vitro and also inhibits hepatic function and regeneration in uivo, we hypothesized that SS-14 might inhibit insulin-induced hepatocyte proliferation in culture and that this model might be a useful tool for studying the mechanism(s) responsible for hepatocyte proliferation.
MATERIALS AND METHODS
Chemicals. Collagenase (type I), media, N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (Hepes), Hanks' buffer, and rat serum albumin were purchased from Sigma (St. Louis, MO). Somatostatin-14 and insulin were obtained from Peninsula Laboratories (Belmont, CA Hepatocyte isolation. Primary cultures of rat hepatocytes were isolated by the method of Gumucio [14] . Briefly, rat liver was portally perfused first with M$+/ Ca2+-free Hanks' buffer at 37°C and then with Eagle's minimal essential medium (EMEM) containing 0.05% collagenase (type I, Sigma). The liver was excised and placed in a petri dish containing fresh EMEM with 0.05% collagenase. Glisson's capsule was stripped and cells were released by gentle manipulation.
The resulting crude preparation was filtered through 250~Frn and 100-pm nylon mesh. Collagenase was inactivated with 0.5 ml fetal calf serum. Viability was in excess of 90% as assessed by trypan blue exclusion.
[3H]Thymidine incorporation assay.
[3H]Thymidine incorporation into DNA was used as a marker for hepatocyte proliferation.
Freshly isolated hepatocytes were plated at a density of lo5 per 16-mm tissue culture dish coated with 250 ~1 Matrigel, (laminin, heparan sulfate, type IV collagen) per well [ 151. After a 24-hr attachment period in EMEM, fresh media including the various peptides was added. After six hr, [3H]thy (2 &i/well) was added and the incubation was allowed to proceed overnight. Cells were removed from the Matrigel with Dispase, a neutral protease produced by Bacillus polymyxa. Half of the cell suspension was used for quantitation of incorporation of [3H]thy; the rest was used to measure DNA content.
Cells for t3H]thy measurement were placed on GF/C Whatman filters, rinsed twice with 1 ml of ice-cold 15% trichloroacetic acid, and then rinsed once with 70% EtOH. Filters were dried, placed in 10 ml of Ecolume scintillation cocktail, and counted in a Beckman LS 6000LL scintillation counter. DNA content was measured with the diphenylamine reaction for desoxypentose.
Cyclic AMP assay. Freshly isolated hepatocytes (105/tube) were incubated with the appropriate reagents for 5 min. At the end of the incubation period, test tubes were placed in a 4°C ice bath for 10 min, vortexed, and centrifuged at 18OOg for 10 min at 4°C. The pellet was precipitated with 15% TCA, ether extracted, and lyophilized. Cyclic AMP levels were measured by competitive protein binding assay using the Amersham kit (Arlington Heights, IL 
RESULTS
Viability and maintenance of differentiated h,epatocyte function in culture.
To rule out the possibility of cell loss as a cause for differences in subsequent experiments, hepatocytes (1 X 105) were incubated for 24 hr in the presence of EMEM, insulin (20 nM), somatostatin-14 (10 nM), or both. On observation under the inverted microscope, cells were uniform in size and shape. Cells were removed from the tissue culture plates by Dispase treatment and cell number was analyzed by both hemocytometer and Coulter counter. No significant differences in cell number, shape, or percentage viability were seen after 24 hr of treatment.
Albumin synthesis was used as a marker for differentiated hepatocyte function. Hepatocytes were incubated in EMEM in the presence or absence of insulin and/or somatostatin-14.
[35S]Cysteine (1 &i) was added to the cultures. Media was aspirated at 24 and 48 hr and analyzed by both immunoprecipitation and immunoblot techniques. Figure 1 into DNA in hepatocyte culture and this effect could be completely abolished by the addition of somatostatin-14 in a dose-dependent manner (Fig. 3) . Autoradiographic study of the nuclear labeling index of cells exposed to EMEM with or without insulin or insulin and somatostatin-14 revealed a 245% increase in la- beled nuclei with insulin which could be reversed by the addition of somatostatin-14 (Fig. 4) . The effect of insulin and somatostatin-14 on cyclic AMP accumulation in hepatocyte culture. A small but reproducible increase in CAMP levels over that seen in cells grown in EMEM alone was detected in hepatocytes stimulated by insulin. This rise in CAMP could be counteracted by the addition of somatostatin-14 (Fig. 5) .
The effect of pertussis toxin on somatostatin inhibition of thymidine incorporation and CAMP accumulation. Pertussis toxin (50 ng) was added to hepatocyte cultures prior to the addition of insulin (20 nM) or somatostatin-14 (10 nM). Pertussis toxin was able to reverse the growth inhibitory effects of somatostatin-14 on thymidine incorporation (Fig. 6 ).
DISCUSSION
In this study, we have shown that somatostatin-14 inhibits insulin-stimulated DNA synthesis in a dose-dependent manner (Fig. 3) . This effect did not result from
Immunoblot of media from rat hepatocytes incubated on Matrigel.
Note the presence of a protein band that stains positive for the rabbit anti-rat albumin antibody in the presence of insulin or somatostatin.
The data are representative of three experiments.
(SS-14, somatostatin-14). The data are representative of six experiments (*P < 0.05).
a toxic injury at the doses used, since the cells appeared viable, cell numbers were similar, and albumin synthesis was not adversely affected. To avoid the possible growth effects of uncharacterized serum components that might affect growth regulation, cells were allowed to grow in media for 24 hr before any growth studies were performed [ 181. This allowed us to carefully analyze the effects of insulin and somatostatin-14 on thymidine incorporation and CAMP content. Inhibition of hepatic regeneration by somatostatin has previously been reported in the 70% hepatectomy rat model; however, it is to determine whether or not somatostatin was exerting a direct or indirect effect on the liver remnant [8] .
The ability of somatostatin to inhibit hepatocyte growth is consistent with its anti-proliferative effects on other cultured cell lines such as mouse splenocytes and human blood T-lymphocytes [19, 20] . Somatostatin has also been shown to inhibit proliferation of FRTL5 rat follicular thyroid cells [5] . Somatostatin can also inhibit certain tumors in several in vivo and in vitro model systems and has lead to speculation that it may be potentially useful in the treatment of certain neoplasms.
Somatostatin appears to inhibit cell growth by both cyclic AMP-dependent and -independent mechanisms. Somatostatin has been shown to inhibit hepatocyte proliferation induced by isobutyl methyl-xanthine and dibutyryl cyclic AMP, both of which act via cyclic AMPdependent mechanisms [21] . Our data show that pretreatment of hepatocytes by pertussis toxin, which increases adenyl cyclase activity by inactivating an inhibitory G protein, blocks the inhibitory effect of somatostatin (Fig. 6) In the present study, we observed a small but reproducible increase in hepatic CAMP levels at 5 min after insulin stimulation. This observation is consistent with the findings of Gettys et al., who used hepatocytes preloaded with a hydrolyzable CAMP analog and documented increased CAMP levels at 0.5-2.0 min followed by a plateau at 5 min and a decline to baseline by 7 min and beyond [25] . This early but transient increase in hepatocyte CAMP after insulin treatment may provide the signal for hepatocytes to initiate mitosis [26] .
Insulin has been shown to antagonize the effects of glucagon on hepatic carbohydrate metabolism despite the synergistic actions of insulin and glucagon on hepatocyte proliferation. This argues against the possibility that alteration of cellular CAMP levels is the major mechanism responsible for the hepatotrophic effects of insulin. More likely, insulin action and the inhibitory effects of somatostatin on insulin action are mediated through cyclic AMP-independent pathways such as protein phosphorylation or calcium influx. The synergistic effects of insulin, glucagon, and epidermal growth factor on hepatocyte growth suggest that each may act through different mechanisms [ 271.
In summary, somatostatin exerts an anti-proliferative effect on insulin-stimulated hepatocytes in vitro. The ability to identify growth inhibitory factors using an in vitro hepatocyte model will hopefully facilitate further studies of the intracellular mechanisms responsible for control of hepatic regeneration.
